Provident Financial plc isn’t the only FTSE 250 stock I’m avoiding right now

Shares in FTSE 250 (INDEXFTSE: MCX) firm Provident Financial plc (LON: PFG) have recovered lately but Edward Sheldon isn’t buying just yet.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

It’s amazing how quickly sentiment can change in the investing world. A stock can literally go from market darling to dud in the blink of an eye. Today, I’m looking at two stocks that have done exactly that, and explaining why I’ll be avoiding both for now.

Provident Financial

This time last year, shares in Neil Woodford favourite Provident Financial (LSE: PFG) were changing hands for around 3,000p. The doorstep lender had enjoyed a solid three years of revenue and profit growth, and its share price had surged as a result. With an attractive dividend yield on offer as well, it was a stock that many investors, myself included, viewed in a positive light.

The picture then changed dramatically. Provident released a profit warning in June, on the back of a change in its operating model, followed by another profit warning and a dividend cut in August. Understandably, the market did not like this at all and by late August the shares were trading under 600p. So is there turnaround potential here?

The group released full-year results in February and it appears that it is slowly working through its issues. It recently completed a £300m rights issue and also agreed a settlement with the FCA in relation to an investigation into its Vanquis Bank arm. The shares have moved higher as a result, and now trade at 930p. Is it time to get on on board?

Neil Woodford recently stated that the business “is now on a stable recovery path” and that “the company’s intrinsic value is substantially higher than the current share price would suggest.”

However, I’m not convinced the stock is a ‘buy’ just yet. The full-year numbers made for some pretty awful reading, with adjusted profit before tax falling 67% and adjusted earnings per share declining 65%. No dividend was paid for the year. As a result, I’ll be staying away from Provident for now.

Cineworld

Cineworld (LSE: CINE) is another stock that has lost its shine recently, albeit for completely different reasons. Unlike Provident, business at the cinema operator is actually chugging along quite nicely at present. Full-year results for FY2017 released this morning revealed an 8% rise in group revenue, a 23% surge in profit before tax, and a 12.3% increase in adjusted diluted EPS for the year. So why did the shares fall 30% between late November and late January?

Investors clearly have doubts about the company’s transformational $5.8bn ‘reverse takeover’ of US cinema giant Regal Entertainment Group. While the acquisition has the potential to transform Cineworld into a key global player, the amount of debt taken on for the deal ($4.1bn) is astronomical.

The huge pile of debt means that the combined group’s net debt is expected to be around four times EBITDA. As my colleague Roland Head recently pointed out, that’s well above the 2.5 times level that is considered to be sensible. Debt of that magnitude adds considerable risk to the investment thesis unfortunately, so for now, I’ll be avoiding the shares.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »